In China, by June 2025, there were already 17 candidates running Phase III clinical trials or already in the pre-market application stage, while in India over 10 companies had submitted requests to the Subject Expert Committee (SEC) to conduct Phase III studies for semaglutide, with 7 of them focusing on oral semaglutide
Effects of fenofibrate therapy on circulating adipocytokines in patients with primary hypertriglyceridemia
Additionally, Foundayo (orforglipron), an innovative oral GLP-1, enhances flexibility without meal or water limits
The remaining author has nothing to disclose
Look for groups specifically focused on weight management and Wegovy to find tailored advice and support
Journal of the National Cancer Institute, 83 (6), 437-441